Clinical data shows significant improvements in depression scores, anxiety measures, and overall quality of life assessments in people who achieve meaningful weight loss with GLP-1 therapy
In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
Hira, T., Trakooncharoenvit, A., Taguchi, H., & Hara, H
Within two weeks, she noticed she looked and felt slimmer
Check with your plan or ask your provider